港股異動 | 港交所(0388.HK)漲2.7%續創新高 獲多家大行看好
格隆匯6月23日丨港交所(0388.HK)現漲2.7%,報320港元續創上市新高,暫成交24.6億港元,最新總市值4057億港元。李小加昨日出席線上論壇時表示,今年將會是香港市場重要的一年,MSCI亞洲系列指數產品選擇落户香港,為香港作為國際金融中心的實力和潛力投下了“信心票”。此外,今年香港市場也會迎來不少“中概股”迴流二次上市。花旗最新發報告指,近日看到港交所增長勢頭有更多正面發展,例如科創板有望納入滬股通北向交易,ETF料可納入股票互聯互通計劃,併為A股衍生品的推出重新燃起了希望,重申其“買入”評級,目標價333港元。此外,大摩、美銀證券亦憧憬市場活動變得更活躍,並預期有更多新產品推出,分別將其目標價上調至345、350港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.